Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)

CAPS Rating: 1 out of 5

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 12/4/2012 10:20:34 AM : Underperform Start Price: $2.18 ONCY Score: -60.36

Only negatives on the horizon

Featured Broker Partners


Advertisement